New Release – HLA Twin RUO 2.1.2

29/06/2017

Omixon has recently announced a major release for HLA Twin, version 2.1.2. – the world’s most accurate, high throughput HLA genotyping software. Thanks to all your feedback and comments, we are delighted to announce a range of new features below: HML improvements New pairwise alignment base...

Omixon Celebrates a Successful EFI 2017

21/06/2017

Thank you to all our friends, customers, co-vendors and distributors for visiting our wonderful new booth, joining our events and just generally hanging out at the 31st annual EFI Meeting in Mannheim, Germany between 30 May-02 June, 2017! Omixon conducted a range of activities, including our very first Distributor...

ASHI Mexico Workshop, July 24-28 2017

19/06/2017

Our small US team will be attending the ASHI Mexico Workshop in July, which will be held in Mexico City. Contact us at sales@omixon.com to arrange a meeting with them. Learn more about the event here…

BioTaiwan, June 28-July 2 2017

19/06/2017

Omixon will be represented by our distributor, TBG at the upcoming BioTaiwan meeting in late June. Visit the official website here…

Human Leukocyte Antigen as a Critical Biomarker for the Adoption of Novel Immunotherapies of Cancer

15/06/2017

– Written by Attila Bérces (Founder and Chairman, Omixon) While the role of HLA has been demonstrated in over hundred diseases, its clinical utility and impact outside transplantation has been limited. Transplantation is still the dominant driver for the clinical HLA typing market. A new therapeutic paradigm in cancer...